secwatch.observer — SEC 8-K summary
======================================

Issuer:     Certara, Inc. (CERT)
CIK:        0001827090
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001827090-25-000034
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Certara Q2 2025 revenue $104.6M (+12% YoY); net loss narrows to $2.0M; reiterates FY guidance
--------------------------------------------------------------------------------

- Revenue $104.6M (+12% YoY); software revenue $46.7M (+22%), services $57.9M (+5%).
- Net loss improved 84% to $2.0M from $12.6M in Q2 2024.
- Adjusted EBITDA $31.9M (+21% YoY); Chemaxon contributed $5.3M to revenue.
- Full-year 2025 financial guidance reaffirmed, citing sustained demand for model-informed drug development.
- CEO highlighted software product enhancements and new product introductions driving long-term growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1827090/000182709025000034/0001827090-25-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1827090/000182709025000034/certara-20250806.htm
  HTML page:      https://secwatch.observer/filing/0001827090-25-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer